Clinical Trial Update: Plasma-Lyte 148® versUs Saline Study [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Plasma-Lyte 148 versus saline for hypovolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypovolemia

Drugs mentioned

• Plasma-Lyte 148 (Plasma-Lyte 148)
• Saline (Sodium chloride solution)

Snippet

Sponsor: The George Institute | Conditions: Hypovolemia | Phase 4 | Status: COMPLETED